Surmodics Inc (SRDX)
26.48
-0.06
(-0.23%)
USD |
NASDAQ |
Apr 17, 16:00
26.48
0.00 (0.00%)
After-Hours: 16:07
Surmodics Price to Book Value: 3.086 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 16, 2024 | 3.093 |
April 15, 2024 | 3.079 |
April 12, 2024 | 3.147 |
April 11, 2024 | 3.226 |
April 10, 2024 | 3.221 |
April 09, 2024 | 3.234 |
April 08, 2024 | 3.204 |
April 05, 2024 | 3.156 |
April 04, 2024 | 3.168 |
April 03, 2024 | 3.142 |
April 02, 2024 | 3.143 |
April 01, 2024 | 3.252 |
March 28, 2024 | 3.419 |
March 27, 2024 | 3.356 |
March 26, 2024 | 3.288 |
March 25, 2024 | 3.198 |
March 22, 2024 | 3.224 |
March 21, 2024 | 3.294 |
March 20, 2024 | 3.359 |
March 19, 2024 | 3.239 |
March 18, 2024 | 3.202 |
March 15, 2024 | 3.283 |
March 14, 2024 | 3.299 |
March 13, 2024 | 3.378 |
March 12, 2024 | 3.422 |
Date | Value |
---|---|
March 11, 2024 | 3.432 |
March 08, 2024 | 3.574 |
March 07, 2024 | 3.514 |
March 06, 2024 | 3.472 |
March 05, 2024 | 3.535 |
March 04, 2024 | 3.688 |
March 01, 2024 | 3.738 |
February 29, 2024 | 3.718 |
February 28, 2024 | 3.795 |
February 27, 2024 | 3.876 |
February 26, 2024 | 3.844 |
February 23, 2024 | 3.822 |
February 22, 2024 | 3.714 |
February 21, 2024 | 3.671 |
February 20, 2024 | 3.679 |
February 16, 2024 | 3.647 |
February 15, 2024 | 3.795 |
February 14, 2024 | 3.850 |
February 13, 2024 | 3.729 |
February 12, 2024 | 3.972 |
February 09, 2024 | 3.813 |
February 08, 2024 | 3.717 |
February 07, 2024 | 3.590 |
February 06, 2024 | 3.584 |
February 05, 2024 | 3.584 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.256
Minimum
Mar 23 2023
5.942
Maximum
Sep 03 2021
4.355
Average
4.384
Median
Dec 28 2023
Price to Book Value Benchmarks
Integer Holdings Corp | 2.606 |
Stryker Corp | 6.872 |
Perspective Therapeutics Inc | 11.12 |
Electromed Inc | 3.031 |
Xtant Medical Holdings Inc | 2.006 |
Price to Book Value Related Metrics
PE Ratio | 69.68 |
PS Ratio | 2.695 |
Price to Free Cash Flow | 37.77 |
Price | 26.48 |
Earnings Yield | 1.44% |
Market Cap | 376.97M |
Operating PE Ratio | 29.78 |
Normalized PE Ratio | 69.55 |